Developmental disabilities for children and teens on the rise


The rate of developmental disabilities for children ages 3 to 17 in the United States rose from 5.76% in 2014 to 6.99% in 2016, according to the CDC. The prevalence of children who’d been diagnosed with a developmental delay other than autism spectrum disorder or intellectual disability also increased from 3.57% to 4.55%.

Prevalence of children diagnosed with any developmental disability from 2014 to 2016

Prevalence of children diagnosed with any developmental disability from 2014 to 2016

Source: National Center for Health Statistics, NCHS Data Brief, No. 291, November 2017

Developmental disabilities are characterized by difficulties in one or more areas, including (but not limited to) learning, behavior, and self-care.

The authors of the National Center for Health Statistics data brief say that the uptick may be a result of improvements in screening for developmental delay, as well as a heightened awareness of the problem.

A smidgen of good news: The rate of autism spectrum disorder and intellectual disability diagnoses held steady during the same period.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.